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Abstract
Everyday movement, whether sitting or running a marathon, exerts stressful
forces on myotendinous junctions (MTJs). As the sites which skeletal muscle fibers
anchor to surrounding extracellular matrix (ECM) material of tendon, MTJsneed to
maintain homeostasis under stress for muscle to function normally. Human congenital
muscular dystrophies (CMDs) are a heterogeneous group ofdiseases that disrupt muscle
homeostasis, are severely debilitating, and currently have no cure. In many CMDs,
genetic mutationseffect cell adhesion complexes located at the MTJ. The adherence of
muscle fibers’ cytoskeleton to the extracellular matrix (ECM) is weakened when these
complexes as compromised. Many genes resulting in muscular dystrophies are currently
identified, yet the fundamental cell processes underlying muscle formation and
attachment are chiefly unknown. This gap in knowledge results in a lack oftissue specific
treatments. This project aims to research whether the overexpression of nicotinamide
ribose kinase 2b (Nrk2b) enzyme, required in a salvage pathway to generate NAD+ and
aid in the regulation of muscle cell adhesion, can be exploited to rescue a form of
congenital muscular dystrophy in the zebrafish model organism. Exploring this pathway
will potentially lead to knowledge that can be applied to gene therapies, using the Nrk2b
kinase as a pharmacological target, and deepening knowledge of the zebrafish model
system for the study of muscle disease.

i

Dedication
A great deal of what worked up to and what work went into my thesis is an
unsettled debt to my grandmother. She continually anticipated more from me in a way
that didn’t demand or require. Resultantly, I hope I have learned to be demanding of
myself in an anticipation of more. This piece of my learning I want to return to her. It is
only a small bit for everything she gave to me (and all the times she sharply scoured the
newspapers’ academic sections for my name- daring me to not be there with a deliberate
grin).

ii

Acknowledgements
There are many people without whom experiencing and completing my thesis
would not have been possible. Foremost, I would like to thank my committee members,
Drs. Henry, Tyler, Dowse, Howard, and Gallagher, very much for your guidance and
attentive feedback throughout this project. I want to especially thank my advisor, Clarissa
Henry, for taking me on and fostering a lab with a collaborative learning and research
environment- a wonderful place for an undergraduate student to begin exploring
biological research.
In the Henry lab, thank you to Mary Astumian for all the help you made readily
available- whether it was experimental help or a willingness to explain and discuss. To
Meghan Kelly and Michelle Goody, thank you for welcoming and guiding me in the lab.
I am particularly grateful to Michelle for the direction your research offered me as well as
your constant willingness to teach and share in my project.
To my family and friends, thank you for all you do even when I am not in the
midst a thesis project. My education and other endeavors would not have been possible
without your support. Though, I want to thank you especially for all those times you
brought me coffee or changed my password to bar me from social networking during my
thesis.
To the Undergraduate Research in Comparative Functional Genomics (INBRE)
Fellowship program, thank you for affording me the ability to prioritize my thesis.
Lastly, thank you to the University of Maine’s Honors College at large for
providing a place that nurtures of exploration in education. It is provided me with some
of the most fun and challenging experiences of my undergraduate years. Thank you!

iii

Table of Contents

Introduction ……………………………………………………………………………… 1
Muscle Function: the journey of contraction ………………………………………... 1
Contraction’s Road from Muscle to Bone: the myotendinous junction……………… 2
Let’s Work Together:the MTJ unit as the whole of many, interactive components…. 3
“Why Me?” Ask Zebrafish: a model system for the study of muscle disease ……….. 6
Working Towards Treatment: congenital muscular dystrophies (CMDs)……………8
Augmenting via Nrk2b: a novel pathway for muscle disease therapy………………...9
Glitches with NAD+ Supplementation as a Therapy………………………………...11
A Case for Studying Nrk2b Overexpression…………………………………………12
Methods and Materials………………………………………………………………...…15
Results………………………………………………………………………………....…19
Discussion……………………………………………………………………………..…24
Figures……………………………………………………………………………………33
References………………………………………………………………………….…….40
Appendix ………………………………………………………………………...………43
About the Author …………………………………………………………..……………44

1

Introduction
Muscle Function: the journey of contraction
The primary function of muscle tissue is contraction. Whether taking notes in
class or summiting a mountain, we depend on muscle contraction. Muscle fibers
comprise highly regulated functional units known as sarcomeres. The primary
machineries of sarcomeres are thin actin and thick myosin II filaments spatially and
functionally regulated by proteins (Ross, 2011). Conciseness of design makes sarcomeres
strong, efficient workers capable of generating power-strokes that cause contraction.
Contractile forces are fundamental to voluntary movement and stable posture.
Contraction is the means eventually translated into an end at the skeleton. An important
question of muscle formation and function is what comes in between. How is contraction
orchestrated into function? The answer is not straightforward or completely understood.
An aim of this study is to elucidate the complexities bridging muscle contraction and
function. Pursuing knowledge of pathways and structures instrumental in normal function
is desirable. It is a vital source for biomedical research, for the knowledge can be
exploited to develop new therapies for muscle disease and dysfunction.
To illustrate the complexities of translating contraction to function, contractile
forces can be approximated to an automobile on a road trip. A road is essential for the socalled contracto-mobile to reach a skeletal destination. To facilitate a successful journey,
the road is constructed with infrastructure and equipped with signaling lights. Being such
a common activity, it is easy to overlook possible dangers of travel. High speeds and
faulty wiring are potential hazards resulting in collision and breakdown. The
consequences compromise the contrato-mobile’s safe arrival. While simplistic and
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imprecise, this sketch demonstrates the inherent need for specialized signals and
structures to transmit contractile forces. Contraction requires a road with integrity and
adaptability that can meet the harsh demands of muscle contraction.

Contraction’s Road from Muscle to Bone: the myotendinous junction
Myotendinous junctions (MTJs) are a section of the road joining muscle and
tendon. They are integrated units responsible for transducing contractile forces from
muscle to the skeletal system and stabilizing joints. While considering the MTJ, imagine
the many stresses muscle and its surrounding tissues are subjected to on a daily basis. The
connections that temper and transfer stressful forces without damaging muscle or
associated nervous, cardiovascular, and connective tissues are truly functional wonders.
Muscle fibers connect to the microenvironment through cell-matrix adhesion complexes.
These connections are not static or purely structural. Instead, to translate numerous and
stressful forces, sites of cell adhesion at the MTJ are dynamic regions capable of
communication and adaption. Collaboration between anchoring complexes and the
microenvironment of the MTJ are essential to muscle development and homeostasis.
Inherited muscle diseases known as congenital muscular dystrophies (CMDs) are
frequently caused by mutations that weaken attachment between cell-matrix adhesion
complexes and the microenvironment. Weakened connections cannot withstand the stress
of contraction, and muscle cell detachment, damage and death may result. There is
currently no cure for the impaired muscle structure and function exhibited in CMDs. The
inherent redundancy and compensation present in cell adhesion are promising resources
for developing new treatments. It is therefore an essential project to examine intricacies
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underlying how cell adhesion occurs at the MTJ in order to understand how to encourage
normal muscle function and homeostasis.

Let’s Work Together:the MTJ unit as the whole of many, interactive components
The components responsible for cell-matrix adhesion at the MTJ are arranged in
what can be described as “overlapping layers” (Fig. 6). Outermost is the extracellular
matrix (ECM). ECM acts as a scaffold for muscle cell attachment and migration. It
comprises structural components, ground substance, proteins, and signaling molecules
that form a vibrant microenvironment. The structural collagen and elastic fibers give
MTJs tensile strength and flexible shape. This scaffold is bathed in a noncellular ground
substance that acts as a hub for signaling factors. Proteoglycans and multi-adhesive
glycoproteinsreplenish noncellular components, participate in cell-matrix signaling, and
facilitate cell adhesion (Ross, 2011; Gilbert, 2003). Proteoglycans consist of proteins
andglycosaminoglycans (GAGs). The GAG component attracts water to the ECM to
resist compressive forces. The ECM microenvironment is designed to be synergistic; it is
in flux to accommodate the needs of muscle tissue. This is not a one-way street though.
Cell and matrix participate in bi-directional interaction to influence compositional
changes needed to modulate development and muscle maintenance. Though uncertain, it
is even projected that the muscle fibers, or cells, themselves are synthesizing and
excreting the surrounding ECM material. The interaction between ECM and muscle
tissue is known as dynamic reciprocity and is vital to accommodate the complex stresses
we incessantly exert on MTJs (Goody and Henry, 2010).
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The formation of a basement membrane exemplifies dynamic reciprocity between
the ECM and muscle fibers. The basement membrane is a specialized sub-compartment
of the ECM and assembles to surround individual muscle fibers. Self-polymerizing
laminin glycoproteins and collagen type IV are the primary components forming the
continuous basement membrane lining muscle cells. The cross-shaped laminins are
heterotrimeric proteins that generate 16 known isoforms from a variable combination of
five α, four β, and three γ chains in vertebrates (Goody and Henry, 2008). Chain
composition in a laminin isoform has tissue-specific function, and its function can be
further specified when laminin receptors are regulated by post-translational events such
as glycosylation (Jimenez-Mallebrera, et al., 2004). As a major component of the
basement membrane, laminins are linking intermediaries between cell-matrix adhesion
receptors and collagen in ECM. Laminin function is not static at the MTJ basement
membrane though. Throughout developmental time, different laminin isoforms
predominate and dissolve. This occurs as they give cues helping to mediate events in
muscle tissue formation (Snow et al., 2008; Peterson and Henry, 2010), such as
notochord morphogenesis (Veeman et al., 2008) and cell spreading (Runyan et al, 1988).
Laminins are responsible for boundary capture preventing cell elongation past the MTJ
(Henry et al., 2005; Snow et al., 2008).
Cell-matrix adhesion is largely dependent on cooperation between laminin and the
prominent cell-matrix adhesion complexes the dystrophin-glycoprotein complex (DGC)
and receptors of the integrin family. The DGC is a large oligomeric complex. In addition
to dystrophin, it is composed of 6 additional membrane-associated proteins. A core
component in the DGC is the heavily glycosylated dystroglycan. The extracellular α
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subunit of dystroglycan binds to laminin while the integral β subunit forges links to the
muscle cell’s actin cytoskeleton (Ervasti and Campbell, 1993).
The integrin complexes are a broad class of transmembrane glycoprotein
receptors. Important to the purposes of this study are integrin α5β1, α6β1, and
α7β1expressed in skeletal muscle tissue. Integrins α5β1 and α6β1 are both present in
muscle development yet have distinct roles. Integrin α5β1 is a fibronectin glycoprotein
receptor crucial to cell migration during the transition of muscle precursor cells into
muscle fibers. While the initial developmental events subside, specifically in the
zebrafish, the fibronectin-rich matrix transitions to a laminin-rich basement membrane,
and integrin α5β1 disbands its major role as integrins α6β1 and α7β1 persist and gain
prevalence. As integrins α6β1 and α7β1 adhere to the ECM via laminin, there is a
dynamic, inter- relationship between integrins and ECM components. An intracellular
integrin cytoplasmic binding protein (MIBP) interacts with the β1 domain and is
expresses during myoblast proliferation to regulate binding affinity for laminin and signal
via the intracellular adaptor protein paxillin (Li et al., 2003). Taken together, the
transitional presence of integrin heterodimers, corresponding ECM glycoproteins, and bidirectional signaling demonstrate cooperation between cell and ECM. While integrin
α7β1 has long been considered the major or exclusive receptor in adult skeletal muscle,
recent findings (to be tucked away for more thorough discussion) have elucidated the
importance of integrin α6β1 in the establishment of a robust basement membrane (Mayer,
2003; Goody et al., 2012) offering a site for stable adhesion to laminin.
Redundancy in cell-matrix adhesion complexes is a point of great importance in
biomedical research. It has been established that dynamic reciprocity occurs at the MTJ.
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The ability to compensate and optimize cellular adaption to stress is part of bi-directional
signaling. In many inherited muscle diseases, the MTJ is stressed to such an extent that
tissues cannot sufficiently adapt and regenerate. This leads to muscle weakness and
dysfunction due to toxicity, cell wasting, cell death, and satellite cell dysfunction
(Morgan, 2010). This does not mean MTJ components give up as soon as one aspect of
normality goes awry. Integrins and the DGC are well-known compensators; if one is
compromised the other increases functionality. This intrinsic compensation is a tool.
Observing and uncovering compensatory patterns may be exploitedin the development
of new therapies.

“Why Me?” Ask Zebrafish: a model system for study of muscle development and disease
To study the intricate redundancies present in muscle tissue and pertinent in
disease research, the zebrafish (Daniorerio) model organism offers an advantageous
paradigm. Despite the fact that teleost fish are more evolutionarily distant from humans
than the mammalian mouse model, numerous traits recommend the zebrafish.
Transparent embryos, external development, short rearing times, high fecundity, and
small size give the model appeal. These characteristics result in easy visualization, large
quantity availability, and rapid development conducive to most research. The
development of somitic muscle segments are, in fact, so visibly apparent as zebrafish
externally develop, they are commonly used as a tool for staging (Kimmel, 1995). In
comparison, the in utero and slower development in the mouse system is less conducive
to this kind of research.
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Shared embryonic origin, anatomical and genetic conservation, and the
organism’s malleability more specifically recommend zebrafish in this type of research.
Muscles of the back in mammals are derived from somites, or somitic mesoderm, and
have a shared embryonic origin to the segmental skeletal muscle of fish also derived from
somites. Somites differentiate into sclerotome, myotome, and dermatome cells that will
respectively become vertebrae, muscle, and dermis tissues. There is a higher proportion
of myotome than sclerotome in zebrafish somites compared to humans (Devoto, et al.,
2006). This allocation results from living in an aquatic environment rather than a
terrestrial one. Muscle tissue is more beneficial for movement within low gravity, viscous
surroundings. Though dissimilar in this way, plentiful skeletal muscle tissue is present for
study. The complexities of cell-adhesion at the MTJ are such that the simplified, plentiful
skeletal muscle in zebrafish is preferred over a less straightforward model.
Chevron-shaped boundaries separating muscle segments are analogous to the
human MTJ. Human and zebrafish MTJs are each rich in extracellular matrix (ECM)
microenvironment, form a basement membrane (BM) sub-compartment, and demonstrate
modified laminin isoform and integrin heterodimer content over developmental time
(Sztal, et al., 2011) demonstrating consistency with human muscle development.
Genetically speaking, orthologous transcripts for all known human dystrophy-causing
genesare currently identified in the zebrafish genome (Steffen, 2007). Combined
advantages of genetics and simple form allow malleability. Zebrafish can be manipulated
as needed using mutant lines, construction of transgenic lines, and reagents to knockdown
specified gene-expression calledmorpholinos(Amsterdam and Hopkins, 2006). These
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features are particularly attractive for research attempting to elucidate functions in, and to
develop treatments for, inherited muscledisease.

Working Towards Treatment: congenital muscular dystrophies (CMDs)
Zebrafish have already been instrumental in research for congenital muscular
dystrophies (CMDs). These are a heterogeneous group of inherited diseases characterized
by progressive muscle tissue weakness and wasting. As may be expected, some CMDs
result when the road between contraction and skeleton fails. Mutations in genes for cellmatrix adhesion receptors and laminin cause CMDs. Those diagnosed experience decline
as their musculature is unable to withstand and regenerate from contractile force. Regular
stresses become too much for, and overwhelm, compromised musculature. CMDs result
in severe debilitation and a drastically shortened lifespan, and there is currently no cure.
Duchenne (DMD) and Becker muscular dystrophies are caused by mutation in the
DGC leading to the complete or partial absence of dystrophin. Congenital muscular
dystrophy with merosin deficiency is caused a laminin α2mutation- essential for major
muscle laminin-2 isoform to polymerize (Berger and Currie, 2012). Congenital muscular
dystrophy with integrin defect is caused by mutation disrupting the integrin α7 chain and
prevents dimerization of integrin α7β1 (Jimenez-Mallebrera et al., 2005). It is not directly
confirmed whether muscle fiber detachment from basement membrane contributes to
human CMDs, for biopsies are procured at a safe distance from tendon. MRI studies do
suggest more severe damage happens closer to the MTJ (Hasegawa, et al., 1992) and
indicate fiber detachment as the instigator of a hostile muscoskeletal environment.

9

Using the zebrafish model, researchers have shown cell-matrix adhesion failure as
the root of muscle cell weakness and apoptosis in several CMDs. Studies have
demonstrated and visualized, for the first time, muscle fibers detach prior to cell
apoptosis in laminin α2 (Hall, et al., 2007), laminin β2 (Jacoby, et al., 2009), and dag1
(Lin, et al., 2011) mutants. Corresponding to the human system, the dag1 morphant
exhibits a phenotype equivalent to human DMD (Parsons et al., 2002; Berger et al.,
2010). Exciting research in a mutant line, demonstrating efficiency of genetic-chemical
screens in zebrafish models, uncovered a compound affecting the cAMP-dependent PKA
signaling effective in treating dystrophin-deficient diseases (Kawahara et al., 2011).
Particularly important to our study, studies using transgenic overexpression as a
therapeutic agent have already shown promise. Enhancing transgenic expression of
integrin α7β1 to compensate absent dystrophin in DMD mice (Burkin, 2001) and of
laminin α2 to partially restore its deficiency in Merosin-deficient mice (Kuang, 1998)
models are examples of such efforts. Studies such as these show how powerful the
combination of the zebrafish model system, uncovering redundancies, and genetic
manipulation is in muscle disease research.

Augmenting Basement Membrane via Nrk2b: a novel pathway for treatingmuscle disease
Cooperation between cell-matrix adhesion complexes and the basement
membrane at the MTJ is important to withstand contractile forces. Discontinuity and
degeneration of the basement membrane are both signs of and causes of muscle disease.
A recent study elucidated a novel pathway in the zebrafish model system, mediated by
integrin α6β1, and necessary for basement membrane formation and maintenance.
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The nicotinamideriboside kinase (Nrk) 1 and 2 pathways in yeast and human cells
are salvage pathways for generating beta Nicotinamide Adenine Dinucleotide (NAD+)
via the phosphorylation of a NicotinamideRiboside precursor (Tempel et al., 2007). The
previously mentioned MIBP is actually a splice variant of Nrk2. Nrk2 is also a suggested
regulator of muscle tissue in these systems. In the zebrafish model, a corresponding
Nrk2b ortholog is required for normal muscle growth and development in vivo and
normal basement membrane assembly at the MTJ (Goody et al., 2010). A strong case was
made for NAD+ synthesis as the primary function of Nrk2b (Goody et al., 2010), for both
exogenous NAD+ and an NAD+ precursor (in the form of niacin/vitamin B3 found in
packaged EmergenC) rescues the nrk2b morphant phenotype.
With this knowledge, researchers asked whether exogenous NAD+ would (1)
ameliorate abnormal basement membranes and (2), if so, be sufficient to rescue muscle
tissue integrity in dystrophic zebrafish. Exogenous NAD+ or EmergenC containing a
NAD+ precursor was added at 6 hours post fertilization (hpf). The time frame is of great
importance, for it allowed incorporation of exogenous NAD+ before the shield stage can
prevent entry of the supplement. In cases of both exogenous NAD+ and EmergenC
supplementation, it was sufficient to rescue the dystrophic phenotype and motility in
dag1 or integrin α7 morphants when accompanied by the integrin α6β1 receptor
(however, from this point forward, the addition of exogenous NAD+ will only be
referenced, seeing asEmergenC contains other components in addition to niacin). It was
found Nrk2b requires integrin α6β1 to mediate NAD+ synthesis, NAD+ causes
localization of paxillin to the MTJ, which leads to increased polymerization of laminin at
the basement membrane. How paxillin localization to the MTJ facilitates laminin
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organization across the membrane is unknown. Paxillin is an important regulator of cell
adhesion turnover; it can both facilitate and degrade cell adhesion.
In a laminin gamma1 mutant zebrafish, addition of exogenous NAD+ would not
rescue dystrophy. Laminin-111 cannot polymerize and form a normal basement
membrane in laminin gamma1 mutants. This suggests the normal basement membrane
microenvironment was sufficient for rescuing dystrophy (Goody et al., 2012). While
there is still much unknown about nrk2b expression, these findings hold therapeutic
potential the nrk2b pathway and augmentation of the basement membrane.

Glitches with NAD+ Supplementation as a Therapy
While these studies have made astonishing strides, NAD+ supplementation is still
far from being a solution for human muscle disease. Three difficulties present immediate
caveats. (1) While comparative analysis of zebrafish and human genomes show
conserved gene function, their systems are separated by 450 million years of evolutionary
departure (Posteltwait et al., 2000). There may be conservation between the zebrafish
nrk2band the human nrk2, but these pathways are also functioning in different systems
with a long history of divergence. In short, what occurs in the zebrafish via nrk2bmediated NAD+ supplementation may be very different from what occurs in humans.
(2) Treatment administration does not correlate between zebrafish and human.
Human muscle diseases, such as congenital muscular dystrophies, are typically not
diagnosed until after birth. If a young boy is diagnosed with DMD, will the alleviating
effects of NAD+ supplementation be enough tohelp in light of the extremity of his
condition? So far, studies have begun treating zebrafish at developmental stages
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equivalent to early in uterohuman development. Whether the results are replicable in
more mature animals is an important question moving forward. NAD+ may not be able to
sufficiently augment basement membrane in older models after early development and
structural establishment of the ECM and basement membrane.
(3) CMDs are very severe forms of muscle disease. NAD+ supplementation has
been shown to reduce dystrophy, but will that be enough to help those with the severest
types of muscular dystrophy? The studies showed muscle fiber detachment rates
decreased, MTJ structure was amended, and motility was improved with vitamin
supplementation. It comes down to whether NAD+ supplementation can bolster the MTJ
microenvironment to a high enough degree to prevent toxicity and inability to stably
regenerate muscle tissue.
While supplementing NAD+ via a vitamin precursor holds promising outlooks for
future research, there are many uncertainties present. NAD+ supplementation currently
does not translate into an effective treatment for a human child diagnosed with DMD.

A Case for Nrk2b Overexpression
The nrk2 pathway can be therapeutically exploited differently from vitamin
supplementation. Gene therapy is an important area of research focused on alleviating
inherited diseases. Gene therapies are attractive, for the treatment is targeted in a tissue
specific manner. In diseases that are often the result of single gene mutation, this
specificity provides a more direct route, whereas NAD+ supplementation through the
blood stream would not be utilized by muscle tissue alone. As mentioned, studies using
transgenic overexpression as a therapy have shown promise. Enhancing transgenic
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expression of integrin α7β1 to compensate absent dystrophin in DMD mice (Burkin,
2001) and of laminin α2 to partially restore its deficiency in Merosin-deficient mice
(Kuang, 1998). Is nrk2b gene therapy a potentially better treatment for CMDs than
NAD+ supplementation?
The purpose of this study is to begin answering this question. So, we asked if
nrk2b overexpression was sufficient to rescue muscular dystrophy in dag1 morphants.
We next hypothesized NAD+ supplementation and nrk2b overexpression
shouldessentially have the same effect, so far as is known. The primary role of both is to
increase NAD+ levels already shown to alleviate muscle form and function in dag1
morphants. We additionally hypothesized overexpressing nrk2b will create a greater
potential for the organism to compensate for the missing DGC. It will do so by cell
autonomous paxillin localization and cell non-autonomous laminin polymerization at the
basement membrane. Taking all into consideration, we hypothesized overexpression of
nrk2b via a transgenic construct would be sufficient to alleviate dystrophy in dag1
morphants.
Exploiting the novel nrk2b pathway for gene therapy in dag1 morphant zebrafish
has potential. As a more direct therapeutic option than supplementation, finding a viable
mode of mimickingnrk2b overexpression may be more effective in the human system.
We constructed an overexpressing nrk2b transgenic line. We detected the integrated
nrk2b genes in the zebrafish when strong GFP expression occurred in F0generation fish.
Only these fish were raised to an age at which they could spawn. Breeding pairs that
spawned consistent, glowing GFP F1generation fish were kept. We utilized F1generation
fish stably expressing GFP to evaluate the therapeutic potential of nrk2b overexpression.
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In this study, we were interested in (1) characterization of the novel nrk2b
overexpressing zebrafish phenotype and (2) determining whether overexpression is
sufficient to alleviate dystrophy when injected with dag1 morpholino. We hypothesized
that a normal zebrafish phenotype would occur in the transgenic zebrafish and that nrk2b
would be sufficient to rescue dag1 induced dystrophy. Muscle tissue and MTJs were
characterized in nrk2b transgenic controls and in nrk2b transgenic/dag1 morphants.
Findings did not support our hypothesis. We observed abnormal MTJ boundaries and
delayed development in nrk2b transgenic controls. Instead of ameliorating dystrophy in
dag1 morphants, the overexpressing nrk2b transgenic fish showed abnormally wide MTJ
angles and detached fibers. These data tentatively suggest nrk2b transgenic zebrafish are
inherently abnormal, and nrk2b overexpression is not sufficient to alleviate dystrophy.
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Methods
Zebrafish (Daniorerio) husbandry
Adult zebrafish were kept at 28.5oC on a 16 hour light and 8 hour dark cycle. I collected
zebrafish embryos from the natural spawning of these adult fish and staged embryos in
accordance with Kimmel et al. (1995). All fish were treated and maintained in
accordance with the University of Maine IACUC.

Transgenic lines
A transgenic line expressing GFP fused to the C-terminus of Nrk2b was generated by
Michelle Goody and Mary Astumian of the Henry lab by cloning full length Nrk2b from
24 hours post fertilization (hpf) zebrafish cDNAthat was prepared as described in
ZFIN:Molecular Methods. The PCR product was cloned into the pDONR221 plasmid
(Invitrogen). The resulting pME, or “middle” clone, was cloned, along with p5E-bactin2
(a non-specific beta-actin promoter- a 5’ entry vector from Tol2Kit (Kwan, 2007)) and
p3E-EGFPpA (EGFP for C-terminal fusions, plus SV40 late polyA- a 3’ entry clone
vector from the Tol2Kit (Kwan, 2007)), via a recombination reaction. Linearized pCS2TP plasmid (provided by Koichi Kawakami) was used as a template to generate capped
mRNA encoding Tol2 transposase by in vitro transcription using SP6 polymerase
(Message Machine, Ambion). Plasmids were co-injected with mRNA encoding Tol2
transposase into wildtype AB embryos at the 1-cell stage using a MPPI-2 Pressure
Injector from ASI. GFP expressing zebrafish from the Fo generation were grown to
maturity and spawned to detect for germ line integration of the transgene. Those of the
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F1generation, the offspring of the Fo generation with germ line integration of the
transgene, stably overexpressing Nrk2b were used for experimentation.

Morpholino (MO) injections
MOs are used to knockdown gene expression through partially blocking cytosolic
initiation of translation or modify pre-mRNA splicing in the nucleus. I used an antisense
morpholino oligonucleotide to partly block dystroglycan translation initiation obtained
from Gene Tools, Inc. The sequence used was 5’CATGCCTGCTTTTATTTTCCCTCGC-3’. It was the same as designed and
microinjected according to Parsons et al. (2002). I injected a volume of 1.4nl into the
yolk of 1-cell stage embryos to deliver 7ng of dystroglycan MO using a MPPI-2 Pressure
Injector from ASI. The morpholino solution I made was a 1:15 dilution of dystroglycan
(5’-CATGCCTGCTTTTATTTTCCCTCGC-3’) in sterile water.

Electrical Stimulation
I electrically stimulated the dag1 morphant and control Nrk2b transgenic zebrafish at 72
hours post fertilization using Grass SD9K-Square Pulse stimulator. This step was taken to
induce depolarization of the muscle membrane and cause a stressful contraction. Normal
muscle should be able to withstand this stress while dystrophic muscle would not
withstand this stress. The stimulator was set at 30V, 8msec duration, 4
pulse/secfrequency, and 6msec delay. Zebrafish were anesthetized in a tricaine solution
(1:125 tricaine in embryo rearing medium) then stimulated for 1 minute per fish by
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positioning the electrode in a head-to-tail direction. I fixed fish in 4% paraformaldehyde
directly they were stimulated.

Fixation
I put embryos undergoing fixation in tubes with 4% Paraformaldehyde (PFA) for 4 hours
at room temperature or overnight at 4oC on their sides. Fixed embryos were washed 5
times for 5 minutes (5x5) in decreasing volumes of 0.1% PBS-Tween.

Phallodin staining
My staining of the fish with Alexa Flour 488 (Molecular Probes) phallodin involved a
series of steps: permeabilizing embryos for 1.5 hours in 2% PBS-Trition, washing 5x5 in
0.1% PBS-Tween, incubation in a 1:20 dilution of in 0.1% PBS-Tween overnight at 4oC,
washing 5x5 in 0.1% PBS-Tween, and storage in 0.1% PBS-Tween.

Mounting
Deyolking occurred in PBS using insect pins under a compound microscope. They were
transferred to 80% glycerol for 5 minutes, side mounted on slides, sealed with cover
slides, and stored in light-protective cases at 4oC.

Imaging
All imaging was completed on a Zeiss Axio Imager Z1 microscope with a Zeiss Apotome
attachment. Slides were viewed under the 10x, 20x, or 40x objective. The filter channels
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38HE (GFP) and 43HE (DsRed) were respectively used to image phallodin and GFP. Zstacks were taken in incremental slices of 1.5 µm.

Measuring and analyzing myotome boundary angles
I measured and calculates the angles of the chevron shaped myotenidinous junctions on
phallodin and GFP stained images using Zeiss Inside 4D software. The angles were
averaged within conditions of treatment. Averages were graphed and statistically
analyzed for significant abnormalities compared to the MTJS angles of wildtype
zebrafish.
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Results
nrk2b transgenic MTJ boundary angles are significantly wider than wildtype control
MTJ boundary angles.
Since the nrk2b overexpressing transgenic is a novel transgenic zebrafish and has
not been characterized, the first question we asked was if the nrk2b transgenic phenotype
was normal. Deleterious effects of nrk2b overexpression would not be conducive to a
gene therapy approach. To investigate, we spawned the transgenic fish strongly
expressing GFP for three rounds of experimentation and simultaneously raised wildtype
controls. Each round, they were grown for 72 hours, because the dag1 morphants’
dystrophic phenotype typically occurs at this time. At this time, they were electrically
stressed with an electrode to test for fiber attachment integrity. We next fixed, stained,
mounted, and imaged the specimens (reference pg. 14 for more specific Methods). We
used phallodin to stain actin to visualize musculature. Muscle tissue mass, striations,
motility and fiber adhesion to MTJ boundaries appeared normal in nrk2b transgenics at
72 hpf. Fiber detachment was present in three of twenty embryos (Fig. 5D, 4.61±14.04
percent myotomes per embryo). However, due to the majority having no detachment, we
speculate these are outliers.
The nrk2b transgenics were developmentally delayed. At 22 hpf, nrk2b
transgenics consistently exhibited 22 somites rather than 26 somites. Another
characteristic indicative of developmental disruption, the nrk2b transgenics also exhibited
abnormally wide MTJ boundary angles.
Using Zeiss Inside 4D software, we measured nrk2b transgenic and wildtype MTJ
angles. In 72 hpf zebrafish, we determined chevron-shaped angles were significantly
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wider in nrk2b transgenics (Fig. 1B) compared to wildtype zebrafish (Fig. 1A) at 72
hpf(Fig. 1C, average MTJ angle for nrk2b transgenic controls, 103.41±8.65 degrees,
p<0.05). This phenotype characteristic of nrk2b overexpression was reminiscent of nrk2b
morphants. In Goody et al. 2010, nrk2b morphants, deficient in Nrk2b, also exhibited
wide MTJ angles (Fig. 1C average MTJ angle for nrk2b morphants, 118.1027±6.84). 100
µm of exogenous NAD+ rescued the nrk2b morphant phenotype (Fig. 1C, average MTJ
angle for nrk2b morphants + 100µm NAD+, 97.6611±8.30), indicating the primary role
of nrk2b was NAD+ synthesis.
The nrk2b morphants are likely Nrk2b deficient. This contrasts with the effect of
nrk2b overexpression, yet the phenotypes of nrk2b morphant and nrk2b overexpressing
zebrafish have striking similarities. The wide angle phenotype is interesting, for it shows
comparable effects of abnormally low and high gene expressions. This is contradictory to
previous studies examining high and low expressions. Previous studies show
contradictory effects of both low and high expression. In a study examining the role of
mutated integrin α6 in prostate cancer, data indicate preventing integrin α6 cleavage will
rescue bone loss and pain, but expression of cleavable integrin α6 results in increased
bone loss and pain (King et al., 2008). How nrk2b high and low expression generates
wide angles is an area for further research.

MTJ boundaries are intact in nrk2b transgenic zebrafish.
To investigate similarities between the nrk2b transgenic and nrk2b morphant
phenotypes, we quantified boundary crossings on images. Wildtype zebrafish have fibers
attached to continuous MTJs at each myotome (Fig. 2A; Fig. 2C, in wildtype controls
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0/282 or 0 percent MTJs were crossed). Discontinuous MTJs and muscle fibers extending
across the MTJ are a hallmark of a disrupted MTJ. In nrk2b morphants, wide angles are
accompanied by significant boundary crossings (Goody et al, 2010; Figure 2E, in nrk2b
morphants 18/87 or 21.42 percent of MTJ were crossed). Along with wide angles,
boundary crossings were rescued by adding exogenous NAD+ (Goody et al, 2010; Fig.
2E, in nrk2b morphants 6/93 or 6.45 percent of MTJ were crossed). The nrk2b transgenic
MTJs were all intact (Fig. 2B; Fig. 2E, in nrk2b transgenics 0/201 MTJs were crossed).
Interestingly, whilenrk2b morphants exhibit crossings, the zebrafish overexpressing
nrk2b have no boundary crossings. Taken together, these data suggest wide angles and
boundary crossings can be mutually exclusive characteristics.

nrk2b transgenic/dag1 morphant MTJ boundary angles are significantly wider than
wildtype control and nrk2b transgenic MTJ boundary angles.
We made fish that were both Dag1-defiecient and nrk2b overexpressing to test
whether the dystrophic phenotype of dag1 morphants was alleviated by the nrk2b
overexpression. We characterized the phenotype of these zebrafish to evaluate whether
nrk2b overexpression would be a viable form of gene therapy for a congenital muscular
dystrophy model.
Occurrence of wide angles was inspected in nrk2b transgenic/dag1 morphants.
We injected dag1 morpholinos to create Dag1-deficient nrk2b transgenic zebrafish.
These fish were also grown until 72 hpf, electrically shocked, and prepared for imaging
as previously described. Wide angles were maintained in thenrk2b transgenic/dag1
morphant phenotype (Fig.3C). Since wide angles are not characteristic of the wildtype
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injected dag1 morphant, it follows that they are a consequence of nrk2b overexpression.
Using angle measurements, we found the nrk2b transgenic/dag1 morphant MTJ angles
were significantly wider than both wildtype and nrk2b transgenic controls (Fig. 3D,
average MTJ angle for nrk2b transgenic/dag1 morphants, 106.78±9.55 degrees, p<0.01
compared to wildtype, p<0.05 compared to nrk2b transgenic control). Exacerbated angles
in nrk2b transgenic/dag1 morphants compared to nrk2b transgenic controls suggest Dag1
and nrk2b expression have a synergistic relationship during the formation of normal
boundary angles.

MTJ boundaries are intact in nrk2b transgenics/dag1 morphant zebrafish.
To investigate whether continuity at the MTJ is maintained with a Dag1deficientcy, we examined the boundary crossings in nrk2b transgenics/dag1
morphantzebrafish.. The nrk2b transgenics/dag1 morphant, like the nrk2b transgenic, has
no boundary crossings and MTJs appear fully intact (Fig, 4A-D, in nrk2b transgenic/dag1
morphants 0/57 or 0% were crossed).

Significant fiber detachment in nrk2b transgenic/dag1 morphants
We had initially asked if nrk2b overexpression in dag1 morphants would be
sufficient to rescue dystrophy. Injection of the dag1 morpholino in wildtypes results in a
phenotype reminiscent of human DMD with significant fiber detachment by 72 hpf
(Panzer et al., 2002;Berger et al., 2010). Given that NAD+ supplementation rescues dag1
morphant fiber detachment, and the primary role of nrk2b is thought to be NAD+
synthesis, we hypothesized that it seems nrk2b overexpression should rescue fiber
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detachment. Taken together, the dag1 morphant + 100µm NAD+ and the nrk2b
transgenic/dag1 morphants should theoretically have similar phenotypes. We visualized
fibers in nrk2b transgenic/dag1 morphants and found the majority of somites had
detached fibers (Fig. 5C-D, 67.44±16.84 percent disrupted myotomes per embryo).
Nrk2b overexpression thus did not alleviate dystrophy in dag1 morphants. If anything,
dystrophy was more severe in the nrk2b transgenic/dag1 morphants than in just dag1
morphants. Rather than rescuing dystrophy, nrk2b overexpression appears to exacerbate
dystrophy in dystroglycan deficient fish.
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Discussion
Significance of Research
Duchenne, Becker, Merosin-deficient, Integrin-deficient, and Fukuyama are
congenital muscular dystrophies disrupting normal cell-matrix interactions at the MTJ
(Berger, 2010; Jimenez-Mallebrera, 2004; Lin, 2011). These are debilitating and lethal
diseases with no current cure. Gene therapy, a relatively new area of study, has received
attention as a potential treatment method for congenital muscular dystrophies. Clinical
trials using viral and non-viral gene therapy methods are ongoing (Brooker, 2011), and
the first human clinical trial for the most frequently occurring congenital muscular
dystrophy, Duchenne muscular dystrophy, began in 2006. Following this trial, three more
immediate trials were planned (Foster et al., 2006). This indicates that the trial broadened
the possibilities and knowledge of how gene therapy may become a viable treatment
option. However, there is still no current cure. Due the difficulties in replacing or
repairing a defected gene and the multifaceted nature of the severe symptoms, research
requires more time and efforts. Human gene therapy trials result from intensive study of
model organisms. Another promising route may be using the Nrk2b kinase as a
pharmacological target. Activating the kinase, rather than maneuvering the complexities
of delivering a gene, is tissue specific and is an emerging therapeutic tactic. With
zebrafish at our fingertips, genetically and anatomically suited to the of study inherited
muscle diseases, we are in a prime position to research prospective gene therapies and
kinases.
Here we are interested in nrk2b gene overexpression as a possible therapy for
multiple congenital muscular dystrophies arising at the MTJ. In this novel salvage
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pathway, Nrk2b mediates NAD+ synthesis. The pathway uses α7β1and requires integrin
α6β1 for NAD+ to improve the basement membrane in zebrafish (Goody et al., 2010; Li
et al., 2003; Goody et al., 2012). NAD+ potentiates paxillin localization and laminin
polymerization to augment the MTJ microenvironment for fiber attachment. Addition of
100µm exogenous NAD+ has already been shown to reduce dystrophy in dag1
morphants (Goody et al., 2012).
Research suggests NAD+ synthesis is the primary role of nrk2b (Goody et al,
2010). Hence, manipulation of nrk2b expression will affect NAD+ synthesis without offtarget effects. Taken together, nrk2b overexpression in a dag1 morphant is theoretically
equivalent to administering exogenous NAD+ to a dag1 morphant. Gene therapy,
however, is a more precise mode of treatment, for it has the advantage of being tissue
specific. We therefore researched whether nrk2b overexpression is sufficient to rescue
dystrophy in the Dag1-deficient, congenital muscular dystrophy model.

Characterization of nrk2b Overexpression in the Transgenic Control: wide MTJ angles
Gene expression should be manipulated with extreme care. Examining the nrk2b
overexpressing phenotype is necessary to detect whether abnormalities are caused by this
particular genetic manipulation. Wide MTJ angles observed suggest developmental
processes are disrupted by nrk2b overexpression. Wildtype zebrafish normally form
chevron-shaped MTJs (Figure 1A). The V-shaped angle of the MTJ boundary is
indicative of normal muscle fiber arrangement required to generate propulsive forces
while swimming (Currie and Ingham, 2001). Complex interactions lead to segmentation
with normal fibers and MTJ angles (Kimmel et al, 1995; Currie and Ingham, 2001).
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Myotomes are initially grouped, cube-shaped precursor cells delineated by early MTJs
oriented at wide angles (Fig. 7). The chevron-shaped angle forms as the muscle precursor
cells striate and elongate into multinucleate myotubes. In an event known as boundary
capture, the MTJ boundary components trap fibers and prevent them from extending past
the MTJ (Henry et al., 2005). Since wide angles are present in nrk2b overexpressing fish,
segmentation is somehow disrupted.
If the primary role of nrk2b expression is to mediate NAD+ synthesis, why is
nrk2b overexpression causing wide boundary angles when adding pure, exogenous
NAD+ does not? Perhaps an obvious answer is that NAD+ synthesis might not be the
singular role of nrk2b expression. nrk2bexpression may have additional effects of which
we are currently unaware. To be pragmatic, speculating the many possible other effects
nrk2b expression may have is outside the scope of this research.
This study can however address the 3-hour time gap between nrk2b expression
andNAD+ supplementation. In Goody et al., exogenous NAD+ was added at 6 hpf. In
contrast, the nrk2b transgene is a zygotic gene, and the maternal-to-zygotic transition
(MZT) initiates its expression. MZT is a process by which zygotic genes are expressed
for the first time as zygotic transcript activation turns on and maternal transcripts
degrade. The first major wave of this MZT in zebrafish occurs at 3 hpf (Tadros et al.,
2009). This leaves a 3 hour window between 3 hpf when nrk2b zygoticoverexpression
first occurs and addition of exogenous NAD+ at 6 hpf to treat zebrafish.
The nrk2b transgene is being expressed between the 512-cell and 1k-cell stages in
the blastula period until shield stage in gastrulation all before NAD+ addition (Kimmel,
1995). Critical events occur at this time. Gastrulation is a period of complex cell
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rearrangements allowing a sheet of cells to transition, according to cell fate, into a three
dimensional embryo. Of particular importance to our study are the cell movements,
known as convergence extension, that shape embryos to become longer along the
anterior-posterior axis and narrower across the mediolateral axis (Fig. 7). Convergence
extension, more succinctly put, is a medio-lateral intercalculation important to body axis
elongation (Wolpert, 2007). During convergence extension, cells migrate towards an
anterior-posterior axis. As more cells arrive, or “converge,” at the so-called axis, they
align in a way that elongates the axis. These medio-lateral intercalculation movements
are reminiscent of a group of children surging forward to gather in a straight line for the
school bus (Fig. 7). The active movements are powered by cell polarity. Polarity
generates lamellipodia that extend cell borders, participating in cell-matrix adhesion turnover, to direct cell migration (Wolpert, 2007). Defects in these movements, occurring in
the 3 hour time window, may cause the wide MTJ angle phenotype seen in nrk2b
transgenics.
A rigorous investigation of this 3-hour window is important in future research.
Using nrk2b transgenics overexpressing nrk2b under control of the heat shock promoter,
we could induce gene overexpression at 6hpf, the time of exogenous NAD+ addition. We
could compare the phenotype when nrk2b overexpression was induced at 6hpf compared
to 3 hpf. Comparing and contrastingof phenotypes would elucidate the affect nrk2b
expression in this space of developmental time.
Comparing the nrk2b morphant phenotype with the nrk2b overexpressing
phenotype, we found the wide angle abnormality is common in both high and low
expressions of nrk2b. As discussed, this is of particular interest simply because high and
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low expressions of nrk2b are inverses. It follows that they would have opposite effects.
As the study on the role of integrin α6 in bone wasting and pain in mice suggests, high
expression and low expression will have different outcomes (King et al., 2008). In this
study, the same abnormality arises from over- and under-expressed nrk2b. These data
suggest there is a balance to be had when it comes to nrk2b expression. There is an
intrinsic ‘just-right’ amount and extremes on either end are detrimental to some of the
same mechanisms. As it has been described in other fields, it falls under the ‘Goldilocks
Principle.’
While discussing extreme and ‘just-right’ amounts, it is important to acknowledge
the dosage response issue in this research. In Goody et al., different doses of exogenous
NAD+ were administered to detect the levels of supplementation sufficient to treat or be
toxic to zebrafish. While there are ways to determinethelevels of NAD+ generated in
excess of wildtype levels in nrk2btransgenics, it is outside the scope of this study to do
so. Although the transgenics utilized in this research stably expressed GFP, we do not
know how frequently the transgene integrated into the genome. Although an incomplete
test of dosage, an important experiment to perform to determine the occurrence and
frequency of nrk2b integration in the genome is a Southern blot. At this time, however,
there is no complementary DNA probe. An in situ hybridization (ISH) is a second option
to determine the presence of mRNA for Nrk2b in the nrk2b transgenic compared to
wildtype zebrafish.
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Characterization of nrk2b Overexpression in the Transgenic Control: boundary
crossings
The average wide MTJ angle is significantly larger in the nrk2b morphant than in
the nrk2b trangenic zebrafish (p<0.01). Boundary crossings are also typical of the nrk2b
morphant phenotype yet are absent in the nrk2b transgenics. As mentioned, this indicates
boundary crossings and wide angles can occur separately. Complicating this observation
is the knowledge that supplementing nrk2b morphants with exogenous NAD+ alleviates
both the boundary crossings and the wide angle phenotype. Taken together, this indicates
that while wide angles and boundary crossings can occur separately, if they occur at the
same time, the defects may exacerbate the phenotype.
Lack of boundary crossings in the nrk2b transgenic suggests that the basement
membrane is continuous. An intact basement membrane is indicative of sufficient laminin
polymerization for capturing fibers at the MTJ. It has been determinednrk2b is non-cell
autonomously required for laminin polymerization at the basement membrane (Goody et
al., 2010). Laminin isoforms also influence various developmental stages like normal
fast-twitch muscle fiber elongation (Snow et al., 2008). The nrk2b morphants were
stained for laminin, and there were gaps throughout the basement membrane where
laminin had not polymerized (Goody et al., 2010). Taken together, the data suggest nrk2b
transgenics have sufficient laminin polymerization to form a continuous boundary that
captures muscle fibers. This makes logical sense, for nrk2b transgenics should be
synthesizing more NAD+ than both nrk2b morphants and wildtypes to potentiate laminin
polymerization at the basement membrane. To investigate these observations further, we
would next stain for laminin-111 in the nrk2b transgenics. It would be interesting if
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laminin organization at the basement membrane was increased in nrk2b overexpressing
fish compared to wildtypes. This might indicate that excess laminin polymerization is
possibly detrimental.

Characterization of nrk2b Overexpression in the dag1 Morphant: wide MTJ angles and
boundary crossings
We next examined the phenotype nrk2b overexpression in a dag1 morphant.
Initially, we hypothesized the nrk2b overexpression would be equivalent to NAD+
supplementation. Meaning, the nrk2b overexpression would augment the basement
membrane to improve the microenvironment to increase fiber attachment integrity. The
unexpected nrk2b transgenic control phenotype, however, indicated the dystrophy in the
dag1 morphant may not be rescued if the MTJ microenvironment was compromised prior
to the augmenting effects of NAD+.
The wide MTJ angles persisted in the dag1 morphant. The angles were even
significantly wider than in the nrk2b transgenic control. This indicates further disruption
at the MTJ, such as in Dystroglycan deficiency, may worsen wide MTJ angles. As we
previously observed, wide angles in the nrk2b morphants were possibly exacerbated by
the additional characteristic of insufficient laminin polymerization. Taken together, these
observations reinforce that the interdependent interactions occurring between the
components maintaining the MTJ integrity are complex.
Boundary continuity was next examined in the nrk2b overexpressing dag1
morphants, and no boundary crossings were observed. This indicates laminin
polymerization was still sufficient, even with Dag1-deficiency, to maintain boundary
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capture. However, as we would in the nrk2b transgenic controls, it is important to
investigate more thoroughly by staining for laminin-111. This would show whether the
basement membrane is continuous in this condition.

Fiber Detachment in nrk2b Overexpressing/dag1 Morphants
With nrk2b overexpression, significant fiber detachment occurred in the dag
morphant. In comparison to previous studies, the fiber detachment was more extreme in
nrk2b overexpressing fish than in wildtype zebrafish injected with dag1 morpholino as
well as Dag-deficient zebrafish treated with 100µm of exogenous NAD+. This may
indicate the nrk2b overexpression and wide angles increased the normal amount of
dystrophy seen in a dag1 morphant. However, there are several uncertainties to consider:
the dosage of NAD+ generated in nrk2b transgenics, the discrepancies between
morpholinos, and the electrical shock we stressed the zebrafish with to test dystrophy.
Each of these may have increased (or decreased) the amount of fiber detachment
observed in the nrk2b overexpressing/dag1 morphants. However, we suspect the MTJ
microenvironment was already not augmented sufficiently to rescue fiber detachment.
While NAD+ supplementation is sufficient to promote the inherent compensation by
integrins, in the absence of dystroglycan, by mediating laminin polymerization and
paxillin localization to organize the basement membrane, nrk2b overexpression was
unable to sufficiently influence formation of a microenvironment conducive to fiber
attachment.
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Conclusion: final thoughts
We approached this project to determine whether nrk2b overexpression in
transgenic zebrafish was sufficient to rescue dystrophy in a congenital muscular
dystrophy model. Instead we opened a can of questions regarding the role of nrk2b
overexpression. The wide MTJ angle phenotype and intact boundaries demonstrate
boundary crossings and wide angles are separate characteristics in the zebrafish
phenotype. Comparable wide angles in nrk2b morphants and nrk2b transgenics further
suggest that there exists a just right amount expression of nrk2b. The just-right amount,
when many gene therapies focus on increasing or decreasing expression, is important to
take into consideration in future studies adjusting nrk2b expression. Both the nrk2b
transgenic control and nrk2b transgenic dag1 morphant phenotypes reveal there is a great
deal unknown about nrk2b expression, and it must be more fully elucidated before it is
considered as a route for gene therapy.
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Figure 1
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Figure 1. The nrk2b overexpressing transgenic zebrafish imaged, side mounted, and
phallodin stained with MTJ angle measurements at 72 hpf. (A) AB wildtype control with
normal MTJ angle measurements depicted. (B) Anrk2b overexpressing transgenic with
the significantly wider MTJ angles. (C) Graph additionally demonstrates the wide angle
phenotype in nrk2b overexpressing transgenics and nrk2b morphants (images not shown).
The nrk2b morphant wide angle phenotype is significantly rescued by NAD+
supplementation (nrk2b morphant/NAD+ data from Goody et al., 2010). These results
demonstrate similar wide MTJ angles in both nrk2b overexpressing transgenic and nrk2b
morphant phenotypes. These results suggest a ‘just-right’ amount of nrk2b gene
expression might occur. Error bars show standard error.
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Figure 2
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Figure 2. The MTJ boundaries exhibit no boundary crossings in nrk2b transgenic
zebrafish imaged, side mounted, and phallodin stained with MTJ angle measurements at
72 hpf. (A) AB wildtype control with no boundary crossings across the MTJs. (B) A
nrk2b overexpressing transgenic with no boundary crossings across the MTJs. (C) The
graph shows that, while boundary crossings don’t occur in nrk2b overexpressing
transgenics, significant boundary crossings occur in the nrk2b morphants (images not
shown). Boundary crossings are rescued in nrk2b morphants when supplemented with
NAD+ (nrk2b morphant/NAD+ data from Goody et al., 2010). These data suggest the
wide MTJ angle and boundary crossings are distinct phenotypic characteristics.
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Figure 3
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Figure 3. The nrk2b transgenic/dag1 morphant has significantly wider MTJ angles than
nrk2b transgenics. Zebrafish are imaged, side mounted, and phallodin stained with MTJ
angle measurements at 72 hpf. (A) AB wildtype control with normal MTJ angle
measurements. (B) Anrk2b overexpressing transgenic with abnormal, wide MTJ angles.
(C) A nrk2b transgenic/dag1 morphant with significantly wider MTJ angles than the
nrk2b overexpressing transgenic. (D) Graph shows the wide MTJ angles are exacerbated
in Dag1-deficient fish. These data suggest dag1 and nrk2b expression synergistically
cause normal MTJ angles.
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Figure 4
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Figure 4. No boundary crossings occur in nrk2b transgenic/dag1 morphants. Zebrafish
are imaged, side mounted, and phallodin stained with MTJ angle measurements at 72 hpf.
(A) AB wildtype control with no boundary crossings across the MTJs. (B) A nrk2b
overexpressing transgenic with no boundary crossings across the MTJs. (C) A nrk2b
transgenic/dag1 morphant with no boundary crossings across the MTJs. (D) Table
indicates neither the nrk2b overexpressing transgenic control nor nrk2b transgenic/dag1
morphants display boundary crossing in their phenotypes. These data call attention to the
observation boundary crossings are distinct from the wide MTJ angle phenotype.
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Figure 5
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Figure 5. Fiber detachment present in nrk2b transgenic/dag1 morphants. Zebrafish are
imaged, side mounted, and phallodin stained with MTJ angle measurements at 72 hpf.
(A) AB wildtype control with no fiber detachment. (B) Anrk2b transgenic control with no
fiber detachment. (C) Anrk2b transgenic/dag1 morphant with detached muscle fibers
(indicated by white arrows). (D) Graph demonstrates the nrk2b transgenic controls have
an outlier percentage of fiber detachment. Compared to dag1 morphants and dag1
morphants rescued with NAD+, nrk2b transgenic/dag1 morphants have exacerbated fiber
detachment (dag1 morphantand dag1 morphant/NAD+ data from Goody et al.,
2010).These data suggest nrk2b overexpression does not alleviate dystrophy but may
exacerbate dystrophy in DAG1-deficient zebrafish.
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Figure
6
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Figure 6.Myotendinous junction components anchoring a muscle cell to the ECM: The
basement membrane is substructure of the ECM and one of its constituents is the laminin
glycoprotein heterotrimers. Muscle cells’ actin cytoskeleton attach to the basement
membrane through transmembrane proteins like the laminin receptors dystroglycan and
integrins. Intracellular proteins, like paxillin, localizing to the sub-membrane zone
organize actin cytoskeleton adhesion.
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Maternal Transcript

Figure 7
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Figure 7.Cell movements occurring in the window of time between zygotic nrk2b
overexpression and addition of NAD+. In MZT, maternal transcripts (green wave)
degrade while zygotic gene expression (purple waves), like nrk2b overexpression, takes
over at 3 hpf in zebrafish. Cell movements during gastrulation happen after 3 hpf. In
convergence extension, the elongated body axis forms as cell migrations narrow mediolateral and elongate anterior-lateral axes. These movements may be disrupted in and
cause the phenotype in nrk2b overexpressing transgenics. Referenced: (Tardos and
Lipshitz, 2009; Wolpert, 2007).
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